{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:01Z","timestamp":1759366441893,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.revmed.2016.02.015","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T10:02:20Z","timestamp":1458900140000},"page":"844-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["R\u00e9cidive neurom\u00e9ning\u00e9e d\u2019une leuc\u00e9mie aigu\u00eb promy\u00e9locytaire r\u00e9v\u00e9l\u00e9e par un syndrome d\u00e9mentiel isol\u00e9"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-3518","authenticated-orcid":false,"given":"O.","family":"Colin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bouyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Meurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Blondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Houeto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Neau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.02.015_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF00873551","article-title":"Reversible dementia: more than 10% or less than 1%? A quantitative review","volume":"242","author":"Weytingh","year":"1995","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2016.02.015_bib0085","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1200\/JCO.2001.19.20.4023","article-title":"Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell\u2019Adulto","volume":"19","author":"Specchia","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2016.02.015_bib0090","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.WNL.0000123249.58898.E0","article-title":"Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease","volume":"62","author":"Schoonenboom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.02.015_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.02.015_bib0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000380913","article-title":"Safety and efficacy of liposomal cytarabine in the treatment of neoplastic meningitis","volume":"89","author":"Jahn","year":"2015","journal-title":"Oncology"},{"year":"2003","series-title":"DSM-IV-TR\u00a0: manuel diagnostique et statistique des troubles mentaux","author":"American Psychiatric Association","key":"10.1016\/j.revmed.2016.02.015_bib0105"},{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.revmed.2016.02.015_bib0110"},{"key":"10.1016\/j.revmed.2016.02.015_bib0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-0-387-69259-3_13","article-title":"Acute promyelocytic leukemia: a paradigm for differentiation therapy","volume":"145","author":"Grimwade","year":"2010","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.revmed.2016.02.015_bib0120","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood-2009-07-233387","article-title":"Very long-term outcome of acute promyelocytic leukemia after treatment with all trans retinoic acid and chemotherapy: the European APL Group experience","volume":"115","author":"Ad\u00e8s","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.02.015_bib0125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/leu.2015.12","article-title":"Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet","volume":"29","author":"Lengfelder","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2016.02.015_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.leu.2404006","article-title":"Extramedullary relapse in acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy","volume":"20","author":"de Botton","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2016.02.015_bib0135","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2141.1998.00871.x","article-title":"Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196\u00a0cases","volume":"102","author":"Guglielmi","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2016.02.015_bib0140","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3324\/haematol.2009.007872","article-title":"Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis","volume":"94","author":"Montesinos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2016.02.015_bib0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.13230","article-title":"Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia","volume":"169","author":"Ohanian","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2016.02.015_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3816\/CLK.2009.n.007","article-title":"Central nervous system relapse in acute promyelocytic leukemia: two cases and a systematic review","volume":"3","author":"Tomblyn","year":"2009","journal-title":"Clin Leuk"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:54Z","timestamp":1759336614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0248866316000837"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.02.015","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9cidive neurom\u00e9ning\u00e9e d\u2019une leuc\u00e9mie aigu\u00eb promy\u00e9locytaire r\u00e9v\u00e9l\u00e9e par un syndrome d\u00e9mentiel isol\u00e9","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}